HERON THERAPEUTICS INC (HRTX) Stock Cash Flow
NASDAQ:HRTX - Nasdaq - US4277461020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.79M | -13.58M | -110.56M | -182.02M | -220.68M | |||
| Depreciation Amortization | 2.35M | 2.49M | 2.90M | 2.89M | 3.02M | |||
| Change In Working Capital | -31.97M | -27.60M | 16.79M | -10.51M | -35.08M | |||
| Interest Paid | 4.85M | 4.86M | 3.06M | 2.25M | 1.24M | |||
| Other non cash items | 15.52M | 16.16M | 32.08M | 42.73M | 49.39M | |||
| OPERATING CASH FLOW | -21.88M | -22.53M | -58.79M | -146.91M | -203.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.81M | -1.71M | -1.54M | -1.83M | -3.02M | |||
| Other Investing Activity | 21.52M | 20.42M | 19.54M | -1.50M | 35.75M | |||
| INVESTING CASH FLOW | 19.71M | 18.71M | 18.00M | -3.32M | 32.73M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 24.35M | 0.00 | 148.96M | |||
| Stock Issued/Repurchased | 993.00K | 940.00K | 29.76M | 75.06M | 7.07M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 993.00K | 940.00K | 54.11M | 75.06M | 156.03M | |||
| CHANGE IN CASH | -1.18M | -2.88M | 13.31M | -75.17M | -14.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.88M | -22.53M | -58.79M | -146.91M | -203.35M | |||
| Capital Expenditure | -1.81M | -1.71M | -1.54M | -1.83M | -3.02M | |||
| FREE CASH FLOW | -23.70M | -24.23M | -60.33M | -148.74M | -206.37M | |||
All data in USD